Abstract

Inflammatory Bowel Disease and Irritable Bowel Syndrome

Clin Exp Dermatol. 2020 Nov 20. doi: 10.1111/ced.14521. Online ahead of print.

K J Kamp 1, S W Matthews 2, M M Heitkemper 2

 
     

Author information

  • 1Division of Gastroenterology, School of Medicine, University of Washington, Seattle, United States.
  • 2School of Nursing, University of Washington, Seattle, United States.

Abstract

We read with interest the article "Feacal Calprotectin in Dermatology Practice".1 The authors discuss the potential use of feacal calprotectin in assessing for inflammatory bowel disease in dermatology practice. Yet, it is important to clarify disease definitions. The article includes the phrase irritable bowel disease, which is not used within the gastrointestinal field. Rather, IBD refers to inflammatory bowel disease in which patients have an underlying mucosal inflammation. ….

© Copyright 2013-2021 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.